These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 32060076)
1. Challenges in molecular diagnosis of Wilson disease. Reeve JL; Frayling IM; Twomey PJ J Clin Pathol; 2020 Apr; 73(4):181-182. PubMed ID: 32060076 [No Abstract] [Full Text] [Related]
2. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin. Davis W; Chowrimootoo GF; Seymour CA Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863 [TBL] [Abstract][Full Text] [Related]
3. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin. Chowrimootoo GF; Ahmed HA; Seymour CA Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167 [TBL] [Abstract][Full Text] [Related]
4. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease. Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851 [TBL] [Abstract][Full Text] [Related]
5. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease. Gollan JL; Stocks J; Dormandy TL; Sherlock S J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874 [TBL] [Abstract][Full Text] [Related]
6. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members. Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594 [TBL] [Abstract][Full Text] [Related]
7. Cultured skin fibroblasts: useful for diagnosis of Wilson's disease? Van den Berg GJ; Van den Hamer CJ; Meijer RJ; Hoogenraad TU J Inherit Metab Dis; 1989; 12(1):64-71. PubMed ID: 2501585 [TBL] [Abstract][Full Text] [Related]
8. ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring. Gaffney D; Fell GS; O'Reilly DS J Clin Pathol; 2000 Nov; 53(11):807-12. PubMed ID: 11127261 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Wilson's disease: an experience over three decades. Gow PJ; Smallwood RA; Angus PW; Smith AL; Wall AJ; Sewell RB Gut; 2000 Mar; 46(3):415-9. PubMed ID: 10673307 [TBL] [Abstract][Full Text] [Related]
10. Western blot analysis in patients with hypocaeruloplasminaemia. Chowrimootoo GF; Andoh J; Seymour CA QJM; 1997 Mar; 90(3):197-202. PubMed ID: 9093597 [TBL] [Abstract][Full Text] [Related]
11. Is Wilson's disease caused by a controller gene mutation resulting in perpetuation of the fetal mode of copper metabolism into childhood? Epstein O; Sherlock S Lancet; 1981 Feb; 1(8215):303-5. PubMed ID: 6109943 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease. Graul RS; Epstein O; Sherlock S; Scheuer PJ Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593 [TBL] [Abstract][Full Text] [Related]
13. Caeruloplasmin isoforms in Wilson's disease in neonates. Chowrimootoo GF; Scowcroft H; Seymour CA Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F198-201. PubMed ID: 10194991 [TBL] [Abstract][Full Text] [Related]